Genomic sequences of a low passage herpes simplex virus 2 clinical isolate and its plaque-purified derivative strain
about
The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.Genomic, phylogenetic, and recombinational characterization of herpes simplex virus 2 strains.Global Diversity within and between Human Herpesvirus 1 and 2 Glycoproteins.Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2.History and genomic sequence analysis of the herpes simplex virus 1 KOS and KOS1.1 sub-strains.Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus.Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract SheddingWorldwide circulation of HSV-2 × HSV-1 recombinant strains.Reliable Detection of Herpes Simplex Virus Sequence Variation by High-Throughput Resequencing.Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents.Molecular evolution of herpes simplex virus 2 complete genomes: Comparison between primary and recurrent infections.Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains.Comparative Analysis of UL16 Mutants Derived from Multiple Strains of HSV-2 and HSV-1 Reveals Species-Specific Requirements for the UL16 Protein.Ultrasensitive Capture of Human Herpes Simplex Virus Genomes Directly from Clinical Samples Reveals Extraordinarily Limited Evolution in Cell Culture.
P2860
Q33610941-93AA8823-B375-4C4A-8F0E-66F723493BEEQ35760461-63441AF3-5993-4203-B0E1-348346F01651Q35914319-8599290B-B03A-43F1-ACFA-766FBE6B51A9Q35914336-813E4C41-1B7A-4555-9026-B34A4E0DF85DQ36373465-64F6EE33-91DC-4E41-A24C-5439613DB5BFQ36553837-B1C04D19-120E-4F34-8A1C-B99500CA8EE1Q36630996-54D7B442-A1D8-452E-85CC-560F23A9D684Q37695200-BB08F51E-A3B7-41B7-A210-48A5574F56BDQ38622361-502D7D76-AA45-4865-A1D9-8CD70DF00813Q40121437-C3745A1F-C26C-4054-A31F-2606C728ED36Q41933426-7E8E7CE7-B753-4659-97B0-0DFD539B9EA3Q45325692-71A9A020-3569-4C64-BAE7-BA189DB0B607Q52431671-49313B6F-7317-4061-BEB8-35C7854AFFB3Q55285515-332B01D9-C261-4379-B81E-29348648C662
P2860
Genomic sequences of a low passage herpes simplex virus 2 clinical isolate and its plaque-purified derivative strain
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genomic sequences of a low pas ...... que-purified derivative strain
@en
Genomic sequences of a low pas ...... ue-purified derivative strain.
@nl
type
label
Genomic sequences of a low pas ...... que-purified derivative strain
@en
Genomic sequences of a low pas ...... ue-purified derivative strain.
@nl
prefLabel
Genomic sequences of a low pas ...... que-purified derivative strain
@en
Genomic sequences of a low pas ...... ue-purified derivative strain.
@nl
P2093
P2860
P1433
P1476
Genomic sequences of a low pas ...... que-purified derivative strain
@en
P2093
David M Knipe
Fernando Diaz
Robert Colgrove
Ruchi Newman
Sakina Saif
Sarah Young
Terry Shea
P2860
P304
P356
10.1016/J.VIROL.2013.12.014
P407
P478
P577
2013-12-31T00:00:00Z